Company news
Pathkey.AI Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Treasury Update
June 25, 2025
OPL & Innovatrix to Launch Clinical Trial Insurance Product
June 18, 2025
OPL Deepens Global AI Collaborations - Cardialysis & Evestia
June 11, 2025
OPL Completes Strategic Review
June 9, 2025
Completion of $1.5m Oversubscribed Placement
May 1, 2025
OPL - Appendix 4D & Half Year Results
February 27, 2025
Opyl Announces Partnership with Avion
February 7, 2025
OPL Signs Landmark JV with X Firm Ltd
January 6, 2025
OPL Signs Partnership Agreement with NeuOrphan
December 10, 2024
OPL Partners L39 Capital to Launch AI-Powered Biotech Fund
December 9, 2024
OPL Signs Service Agreement with Southern CDC
November 20, 2024
Updated Quarterly Activities & Cashflow Report
October 29, 2024
Opyl Signs New Service Agreement with Commercial Eyes
October 15, 2024
Opyl Signs New Service Agreement with Biointelect
September 24, 2024
Strategic Partnership with Phenix Health Compendium Platform
September 22, 2024
Opyl Enters Strategic Partnership with Alithia Life Sciences
September 16, 2024
Opyl - Full Year Results
August 29, 2024
Opyl - Appendix 4E
August 29, 2024
Opyl Secures $700K loans to advance TrialKey & Drive Growth
August 21, 2024
Opyl - Business Update & Appendix 4C
July 30, 2024
OPL signs MOU for EMEA & US Expansion
July 23, 2024
Opyl Partners with L39 Capital to Launch AI Biotech Fund
July 8, 2024
Opyl Announces First Trial Gen Revenue & Customer
June 5, 2024
Opyl signs binding agreement for sale of Opin business
April 22, 2024
Reinstatement to Quotation
March 22, 2024
Opyl receives non-binding offer for its Opin business
March 22, 2024
Suspension from Quotation
March 21, 2024
Request for Trading Halt
March 20, 2024
Pause in Trading
March 20, 2024
Successful Placement of Rights Issue Shortfall
February 7, 2024
Opin Signs New $282K Patient Recruitment Contract
February 4, 2024
Rights Offer Booklet
December 21, 2023
Opyl Opens Rights Offer
December 21, 2023
Opyl completes Placement and launches Entitlement Offer
December 12, 2023
Opyl Appoints Chief Executive Officer
November 23, 2023
Opyl Receives $530K R&D Tax Refund
September 21, 2023
TrialKey MVP Launched / Strategy Update Webcast
August 24, 2023
Opyl Announces Leadership Changes & Strategic Realignment
July 5, 2023
Opyl completes Placement and secures short term loan
July 3, 2023
Successful Placement of Shortfall Shares from Rights Issue
April 4, 2023
Appendix 4D & Half Year Results
February 26, 2023
Opyl enters into MSA and new clinical trial recruitment
January 17, 2023
Opyl completes Placement and launches Rights Issue
December 23, 2022
Suspension from Official Quotation
December 23, 2022
Opyl - world-first mapping & linking clinical trial data
October 19, 2022
Opyl Receives $570K R&D Tax Refund
October 18, 2022
Opyl - Appendix 4E & Annual Report
August 30, 2022
Opyl - FY22 Results Announcement
August 30, 2022
Opyl 2021 AGM Presentation 18 November 2021
November 18, 2021
Opyl - August Full Year Investor Update
August 30, 2021
Decks
The 5 newest of 6 decks. Every deck is listed under its year.
- Shareholder Meeting (November 2026)
Shareholder meeting · 26 slides · Nov 5, 2026
- Investor Presentation (June 2026)
Investor deck · 11 slides · Jun 24, 2026
- Shareholder Meeting (November 2021)
Shareholder meeting · 15 slides · Nov 18, 2021
- Investor Presentation (May 2021)
Investor deck · 16 slides · May 24, 2021
- Investor Presentation (February 2021)
Investor deck · 17 slides · Feb 25, 2021